---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-052093"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:48:39.131148+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology loses two directors; board drops below majority independent; cure period triggered

## Summary
- Jack Nielsen resigned April 28 for health; Itziar Canamasas resigned April 30 due to new professional role.
- Board reduced to six directors, only three independent, breaching Nasdaq majority requirement.
- Company invokes 180-day cure period under Nasdaq Rule 5605(b)(1)(A) to restore independent majority.
- Scott Garland reclassified from Class III to Class II director, effective May 1.
- Audit, Compensation, and Governance committees reconstituted with Garland, Goodman, Hemrajani.

## SEC filing metadata
- accession: 0000950170-24-052093
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000095017024052093/0000950170-24-052093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000095017024052093/alxo-20240428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-052093
- JSON: https://secwatch.observer/filing/0000950170-24-052093.json
- Plain text: https://secwatch.observer/filing/0000950170-24-052093.txt

## Key facts
- Executive change
  Itziar Canamasas resigned as member of the Board of Directors at ALX ONCOLOGY HOLDINGS INC.
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On April 30, 2024, Itziar Canamasas, Ph.D., informed the Company of her resignation as a member of the Board and all committees thereof, effective immediately, due to her taking a new professional position that does not permit her to continue on as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810182/000095017024052093/0000950170-24-052093-index.htm
- Executive change
  Jack Nielsen resigned as member of the Board of Directors at ALX ONCOLOGY HOLDINGS INC.
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On April 28, 2024, Jack Nielsen informed ALX Oncology Holdings Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and all committees thereof, effective immediately, due to health reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810182/000095017024052093/0000950170-24-052093-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.